These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21059256)

  • 1. Assessing the effects of multiple infections and long latency in the dynamics of tuberculosis.
    Yang HM; Raimundo SM
    Theor Biol Med Model; 2010 Nov; 7():41. PubMed ID: 21059256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practical aspects of backward bifurcation in a mathematical model for tuberculosis.
    Gerberry DJ
    J Theor Biol; 2016 Jan; 388():15-36. PubMed ID: 26493359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emergence of latent infection in the early evolution of Mycobacterium tuberculosis.
    Chisholm RH; Tanaka MM
    Proc Biol Sci; 2016 May; 283(1831):. PubMed ID: 27194699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Backward bifurcation and hysteresis in models of recurrent tuberculosis.
    Wangari IM; Stone L
    PLoS One; 2018; 13(3):e0194256. PubMed ID: 29566101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. M. tuberculosis persistence, latency, and drug tolerance.
    Gomez JE; McKinney JD
    Tuberculosis (Edinb); 2004; 84(1-2):29-44. PubMed ID: 14670344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology.
    Yang Z; Rosenthal M; Rosenberg NA; Talarico S; Zhang L; Marrs C; Thomsen VØ; Lillebaek T; Andersen AB
    Infect Genet Evol; 2011 Jul; 11(5):1164-7. PubMed ID: 21315848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding virulence mechanisms in M. tuberculosis infection via a circuit-based simulation framework.
    May E; Leitao A; Faulon JL; Joo J; Misra M; Oprea TI
    Annu Int Conf IEEE Eng Med Biol Soc; 2008; 2008():4953-5. PubMed ID: 19163828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FasL regulatory B-cells during Mycobacterium tuberculosis infection and TB disease.
    Loxton AG; van Rensburg IC
    J Mol Biol; 2021 Jun; 433(13):166984. PubMed ID: 33845087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling intercellular interactions in early Mycobacterium infection.
    Warrender C; Forrest S; Koster F
    Bull Math Biol; 2006 Nov; 68(8):2233-61. PubMed ID: 17086496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
    Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
    Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection.
    Salgame P
    Curr Opin Immunol; 2005 Aug; 17(4):374-80. PubMed ID: 15963709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existence of multiple-stable equilibria for a multi-drug-resistant model of Mycobacterium tuberculosis.
    Gumel AB; Song B
    Math Biosci Eng; 2008 Jul; 5(3):437-55. PubMed ID: 18616351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimally capturing latency dynamics in models of tuberculosis transmission.
    Ragonnet R; Trauer JM; Scott N; Meehan MT; Denholm JT; McBryde ES
    Epidemics; 2017 Dec; 21():39-47. PubMed ID: 28641948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lazy, dynamic or minimally recrudescent? On the elusive nature and location of the mycobacterium responsible for latent tuberculosis.
    Ehlers S
    Infection; 2009 Apr; 37(2):87-95. PubMed ID: 19308316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is
    Behr MA; Edelstein PH; Ramakrishnan L
    BMJ; 2019 Oct; 367():l5770. PubMed ID: 31649096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Mycobacterium bovis persist in cattle in a non-replicative latent state as Mycobacterium tuberculosis in human beings?
    Sabio Y García J; Bigi MM; Klepp LI; García EA; Blanco FC; Bigi F
    Vet Microbiol; 2020 Aug; 247():108758. PubMed ID: 32768211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of airborne transmission of Mycobacterium tuberculosis: implications for control of tuberculosis in the HIV era.
    Fennelly KP
    Clin Infect Dis; 2007 May; 44(10):1358-60. PubMed ID: 17443475
    [No Abstract]   [Full Text] [Related]  

  • 19. Microbe Profile: Mycobacterium tuberculosis: Humanity's deadly microbial foe.
    Gordon SV; Parish T
    Microbiology (Reading); 2018 Apr; 164(4):437-439. PubMed ID: 29465344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection.
    Schuck SD; Mueller H; Kunitz F; Neher A; Hoffmann H; Franken KL; Repsilber D; Ottenhoff TH; Kaufmann SH; Jacobsen M
    PLoS One; 2009; 4(5):e5590. PubMed ID: 19440342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.